8/13/2019 DHF bleeding
1/20
8/13/2019 DHF bleeding
2/20
INFEKSI
DENGUEASIMTOMATIK
SIMTOMATIK
TANPAPERDARAHAN
DENGAN
PERDARAHAN
TIDAK MASSIF
SYOK TANPA SYOK
MASSIF
8/13/2019 DHF bleeding
3/20
Average annual number dengue fever (DF) and denguehaemorrhagic fever (DHF) cases reported to WHO, and of
countries reporting dengue, 1955-2007
8/13/2019 DHF bleeding
4/20
Dengue guidelines for diagnosis, treatment, prevention, and control. World Health Organization, UNICEF,
UNDP. New Edition 2009.
8/13/2019 DHF bleeding
5/20
Trombosit
Kompleks
Ag-Ab
Trombosit
dihancurkan
Agregasi
terganggu
Perdarahan
Permeabilitas
Kapiler
Mediator
8/13/2019 DHF bleeding
6/20
8/13/2019 DHF bleeding
7/20
8/13/2019 DHF bleeding
8/20
Manifestasi : Perdarahan pada DBD
Tes Rumpel positif
Epistaksis
Haemoptoe
Perdarahan gusiPerdarahan sal. Makanan
Hematuria
Hipermenore
8/13/2019 DHF bleeding
9/20
Grading The Severity of DHF
Grade I:
Fever accompanied by non-specific constitutional symptoms; the onlyhemorrhagic manifestation is a positive tourniquet test.
Grade II:
Spontaneous bleeding in addition to the manifestations of Grade I
patients, usually in the form of skin and/or other hemorrhagic. Grade III:
Circulatory failure manifested by rapid and weak pulse, narrowing of
pulse pressure (20 mmHg or less )or hypertension, with the presence ofcold clammy skin and restlessness
Grade IV:
Profound shock with undetectable blood pressure and pulse
8/13/2019 DHF bleeding
10/20
Massive bleeding s usually from :
Gastrointestinal tract,
Vagina inadult females.
Internal bleeding may not become apparent for many hours
until the firstblack stool is passed.
WHO 2009
8/13/2019 DHF bleeding
11/20
Have prolonged/refractory shock;
Hypotensive shock and :
Renal
Liver failureSevere andpersistent metabolic acidosis
Given non-steroidal anti-inflammatory agents
Pre-existing peptic ulcer disease
On anticoagulant therapyHave any form of trauma
including intramuscular injection.
WHO 2009
Patients at risk of major bleeding
8/13/2019 DHF bleeding
12/20
WHO 2009
Severe bleeding can be recognized by:
Persistent and/or severe overt bleeding +unstable
haemodynamic status
Haematocrit after fluid resuscitation +
unstablehaemodynamic status
Refractory shock that fails to respond to
consecutive fluid resuscitation of40-60 ml/kg
Hypotensive shock with low/normal haematocrit before
hypotensive shock
Persistent or worsening metabolic acidosis
8/13/2019 DHF bleeding
13/20
Give 510ml/kg of fresh-packed red cells
or 1020 ml/kg of fresh wholeblood at an appropriate rate
observe the clinical response.
A good clinical responseImproving haemodynamic status
Acid-base balance.
WHO 2009
Consider repeating the blood transfusion if :
Further blood loss or
Noappropriate rise in haematocrit after blood transfusion
The action plan for the treatment of
haemorrhagic complications :
8/13/2019 DHF bleeding
14/20
Penatalaksanaan Perdarahan Spontan
Perdarahan Spontan dan Masif: - Epistaksis tidak terkendali
- Hematemesis melena- Perdarahan otak
Bila Hct < 30 %Transfusi PRC segar 5 10 ml/kgBB
Atau WBC Segar 10 20 ml/kgBB
Transfusi komponen darah :* FFP (bila APTT > 1,5 X normal )
* Trombosit (bila Tromb.
8/13/2019 DHF bleeding
15/20
8/13/2019 DHF bleeding
16/20
Tatalaksana Syok HipotensifInfus Kristalloid/Kolloid 20 ml/kgBB selama 15 menit
PERBAIKAN
TETAP SYOK
Kolloid 10-20 ml/kgBB
Selama - 1 jam
Ht k
Transfusi PRC
10 ml/kgBB
Ht k
TETAP SYOK
Kristalloid7 10 ml/kgBB
1 2 jam
WHO 2010
PERBAIKAN
PERBAIKAN
Kristalloid5 7 ml/kgBB
1 2 jam
Kristalloid3 5 ml/kgBB2 4 jam
PERBAIKAN
Kristalloid 2 3 ml/kgBB2 4 JAM TURUNKAN
8/13/2019 DHF bleeding
17/20
8/13/2019 DHF bleeding
18/20
Kasa basah, darah segar merembes
8/13/2019 DHF bleeding
19/20
Perdarahan hebat akibat DIC pada DSS
8/13/2019 DHF bleeding
20/20